![John R. Garrett](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van John R. Garrett
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Glycosyn LLC
![]() Glycosyn LLC Pharmaceuticals: MajorHealth Technology Glycosyn LLC is a biotechnology-based company that develops efficient and cost-effective technologies for synthesizing and producing human milk oligosaccharides (HMOs). The private company is based in Medford, MA. HMOs are major health-giving components of human milk, and Glycosyn owns exclusive rights for methods of manufacturing HMOs as well as for their use in treating inflammatory bowel disease and irritable bowel syndrome, and as prebiotics. Glycosyn Health Initiatives (GHI) is a non-profit dedicated to bringing the benefits of HMOs to those who need them most in the developing world. The CEOs of the company are Howard Newburg, John R. Garrett. | Algemeen Directeur | - | - |
Glycosyn Health Initiatives, Inc. | Directeur/Bestuurslid | - | - |
Loopbaan van John R. Garrett
Eerdere bekende functies van John R. Garrett
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ADVANCED PROTEOME THERAPEUTICS CORPORATION | Directeur/Bestuurslid | 16-04-2018 | - |
Statistieken
Internationaal
Verenigde Staten | 3 |
Canada | 2 |
Operationeel
Director/Board Member | 2 |
Chief Executive Officer | 1 |
Sectoraal
Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ADVANCED PROTEOME THERAPEUTICS CORPORATION | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Glycosyn LLC
![]() Glycosyn LLC Pharmaceuticals: MajorHealth Technology Glycosyn LLC is a biotechnology-based company that develops efficient and cost-effective technologies for synthesizing and producing human milk oligosaccharides (HMOs). The private company is based in Medford, MA. HMOs are major health-giving components of human milk, and Glycosyn owns exclusive rights for methods of manufacturing HMOs as well as for their use in treating inflammatory bowel disease and irritable bowel syndrome, and as prebiotics. Glycosyn Health Initiatives (GHI) is a non-profit dedicated to bringing the benefits of HMOs to those who need them most in the developing world. The CEOs of the company are Howard Newburg, John R. Garrett. | Health Technology |
Glycosyn Health Initiatives, Inc. |
- Beurs
- Insiders
- John R. Garrett
- Ervaring